

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.28372072 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.73309683 |
| 3 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.59821754 |
| 4 | protein localization to kinetochore (GO:0034501) | 4.50187521 |
| 5 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.34131508 |
| 6 | establishment of integrated proviral latency (GO:0075713) | 4.29842991 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 4.28468472 |
| 8 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.24228871 |
| 9 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.23352249 |
| 10 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.20544896 |
| 11 | negative regulation of ligase activity (GO:0051352) | 4.20544896 |
| 12 | DNA unwinding involved in DNA replication (GO:0006268) | 4.19174303 |
| 13 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.09845404 |
| 14 | formation of translation preinitiation complex (GO:0001731) | 4.08876754 |
| 15 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.98303137 |
| 16 | ATP synthesis coupled proton transport (GO:0015986) | 3.95793444 |
| 17 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.95793444 |
| 18 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.93597832 |
| 19 | DNA replication initiation (GO:0006270) | 3.93537706 |
| 20 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.83528193 |
| 21 | DNA strand elongation (GO:0022616) | 3.78407955 |
| 22 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.76102710 |
| 23 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.76102710 |
| 24 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.76102710 |
| 25 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.75764678 |
| 26 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.75764678 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 3.75127730 |
| 28 | establishment of viral latency (GO:0019043) | 3.74969047 |
| 29 | mitotic nuclear envelope disassembly (GO:0007077) | 3.73557369 |
| 30 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.71942898 |
| 31 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.71942898 |
| 32 | mitotic sister chromatid segregation (GO:0000070) | 3.70583599 |
| 33 | DNA deamination (GO:0045006) | 3.69851372 |
| 34 | protein localization to chromosome, centromeric region (GO:0071459) | 3.68767568 |
| 35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.67958849 |
| 36 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.67419088 |
| 37 | protein neddylation (GO:0045116) | 3.66907123 |
| 38 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.63267100 |
| 39 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.63267100 |
| 40 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.59279396 |
| 41 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.55929587 |
| 42 | respiratory chain complex IV assembly (GO:0008535) | 3.54416234 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.52913551 |
| 44 | rRNA modification (GO:0000154) | 3.52677573 |
| 45 | ribosome biogenesis (GO:0042254) | 3.52493257 |
| 46 | nuclear pore organization (GO:0006999) | 3.49771713 |
| 47 | nucleobase biosynthetic process (GO:0046112) | 3.48201538 |
| 48 | positive regulation of ligase activity (GO:0051351) | 3.47896274 |
| 49 | nuclear pore complex assembly (GO:0051292) | 3.46781262 |
| 50 | regulation of gene silencing by RNA (GO:0060966) | 3.43311370 |
| 51 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.43311370 |
| 52 | regulation of gene silencing by miRNA (GO:0060964) | 3.43311370 |
| 53 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.43086476 |
| 54 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.43086476 |
| 55 | DNA replication checkpoint (GO:0000076) | 3.43034338 |
| 56 | membrane disassembly (GO:0030397) | 3.42465700 |
| 57 | nuclear envelope disassembly (GO:0051081) | 3.42465700 |
| 58 | IMP biosynthetic process (GO:0006188) | 3.40831102 |
| 59 | cytochrome complex assembly (GO:0017004) | 3.37590902 |
| 60 | ribosomal small subunit assembly (GO:0000028) | 3.37439211 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.36558597 |
| 62 | heterochromatin organization (GO:0070828) | 3.36093938 |
| 63 | dosage compensation (GO:0007549) | 3.35988527 |
| 64 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.35623830 |
| 65 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.35005499 |
| 66 | DNA duplex unwinding (GO:0032508) | 3.34301966 |
| 67 | respiratory electron transport chain (GO:0022904) | 3.33199974 |
| 68 | DNA geometric change (GO:0032392) | 3.31652136 |
| 69 | mitotic metaphase plate congression (GO:0007080) | 3.31010875 |
| 70 | sister chromatid segregation (GO:0000819) | 3.30315513 |
| 71 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.29056615 |
| 72 | DNA ligation (GO:0006266) | 3.26471176 |
| 73 | electron transport chain (GO:0022900) | 3.24566992 |
| 74 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.24209362 |
| 75 | chromatin remodeling at centromere (GO:0031055) | 3.22626197 |
| 76 | telomere maintenance via recombination (GO:0000722) | 3.21141213 |
| 77 | protein targeting to mitochondrion (GO:0006626) | 3.21109904 |
| 78 | CENP-A containing nucleosome assembly (GO:0034080) | 3.20856438 |
| 79 | termination of RNA polymerase III transcription (GO:0006386) | 3.19707684 |
| 80 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.19707684 |
| 81 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.17588971 |
| 82 | protein complex biogenesis (GO:0070271) | 3.16780275 |
| 83 | regulation of ligase activity (GO:0051340) | 3.16167175 |
| 84 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.14756034 |
| 85 | regulation of translational fidelity (GO:0006450) | 3.13079514 |
| 86 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.12131655 |
| 87 | protein deneddylation (GO:0000338) | 3.11716091 |
| 88 | deoxyribonucleotide catabolic process (GO:0009264) | 3.11068369 |
| 89 | mitotic chromosome condensation (GO:0007076) | 3.10950845 |
| 90 | purine nucleobase biosynthetic process (GO:0009113) | 3.10461398 |
| 91 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.10324486 |
| 92 | maturation of SSU-rRNA (GO:0030490) | 3.08503249 |
| 93 | regulation of cellular amine metabolic process (GO:0033238) | 3.08233856 |
| 94 | deoxyribose phosphate catabolic process (GO:0046386) | 3.07892573 |
| 95 | L-serine metabolic process (GO:0006563) | 3.07359501 |
| 96 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.07287722 |
| 97 | viral transcription (GO:0019083) | 3.06494445 |
| 98 | mitotic recombination (GO:0006312) | 3.06488096 |
| 99 | telomere maintenance via telomere lengthening (GO:0010833) | 3.02980023 |
| 100 | pre-miRNA processing (GO:0031054) | 3.02795166 |
| 101 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.01920150 |
| 102 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.01138662 |
| 103 | inner mitochondrial membrane organization (GO:0007007) | 3.01087448 |
| 104 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.00664000 |
| 105 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.00664000 |
| 106 | negative regulation of protein ubiquitination (GO:0031397) | 3.00635823 |
| 107 | negative regulation of RNA splicing (GO:0033119) | 2.99025872 |
| 108 | establishment of protein localization to mitochondrion (GO:0072655) | 2.98804124 |
| 109 | translational termination (GO:0006415) | 2.97024439 |
| 110 | IMP metabolic process (GO:0046040) | 2.96743659 |
| 111 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.96517106 |
| 112 | oxidative phosphorylation (GO:0006119) | 2.96426827 |
| 113 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.96257092 |
| 114 | translational initiation (GO:0006413) | 2.92786289 |
| 115 | protein localization to mitochondrion (GO:0070585) | 2.90864477 |
| 116 | translation (GO:0006412) | 2.89838327 |
| 117 | negative regulation of histone methylation (GO:0031061) | 2.89094817 |
| 118 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.89018229 |
| 119 | rRNA processing (GO:0006364) | 2.88596805 |
| 120 | cullin deneddylation (GO:0010388) | 2.88259005 |
| 121 | histone H4-K12 acetylation (GO:0043983) | 2.87925730 |
| 122 | positive regulation of cell cycle arrest (GO:0071158) | 2.87907272 |
| 123 | regulation of spindle organization (GO:0090224) | 2.87508610 |
| 124 | replication fork processing (GO:0031297) | 2.85156512 |
| 125 | rRNA methylation (GO:0031167) | 2.84102577 |
| 126 | ribosomal small subunit biogenesis (GO:0042274) | 2.84098778 |
| 127 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.83647779 |
| 128 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.83524534 |
| 129 | chromatin assembly (GO:0031497) | 2.83244681 |
| 130 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.82872259 |
| 131 | translational elongation (GO:0006414) | 2.82750886 |
| 132 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.82681931 |
| 133 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.81430864 |
| 134 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.80845211 |
| 135 | positive regulation of chromosome segregation (GO:0051984) | 2.80344423 |
| 136 | pore complex assembly (GO:0046931) | 2.79728752 |
| 137 | rRNA metabolic process (GO:0016072) | 2.79234942 |
| 138 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.79226302 |
| 139 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.77819735 |
| 140 | DNA double-strand break processing (GO:0000729) | 2.76479914 |
| 141 | regulation of translational termination (GO:0006449) | 2.76236921 |
| 142 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.75754159 |
| 143 | ribosome assembly (GO:0042255) | 2.75620873 |
| 144 | metaphase plate congression (GO:0051310) | 2.75229438 |
| 145 | regulation of histone H3-K9 methylation (GO:0051570) | 2.75030559 |
| 146 | negative regulation of mRNA processing (GO:0050686) | 2.74966591 |
| 147 | base-excision repair (GO:0006284) | 2.73905267 |
| 148 | DNA damage response, detection of DNA damage (GO:0042769) | 2.73721449 |
| 149 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.73161488 |
| 150 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.73161488 |
| 151 | NADH dehydrogenase complex assembly (GO:0010257) | 2.73161488 |
| 152 | nuclear envelope organization (GO:0006998) | 2.72672349 |
| 153 | maturation of 5.8S rRNA (GO:0000460) | 2.72296662 |
| 154 | RNA splicing, via transesterification reactions (GO:0000375) | 2.71912891 |
| 155 | mRNA splicing, via spliceosome (GO:0000398) | 2.71268669 |
| 156 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.71268669 |
| 157 | cellular component biogenesis (GO:0044085) | 2.70348716 |
| 158 | regulation of translation in response to stress (GO:0043555) | 2.68747753 |
| 159 | spliceosomal snRNP assembly (GO:0000387) | 2.68593219 |
| 160 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.68480265 |
| 161 | protein maturation by protein folding (GO:0022417) | 2.68470310 |
| 162 | DNA conformation change (GO:0071103) | 2.68399832 |
| 163 | GDP-mannose metabolic process (GO:0019673) | 2.68279688 |
| 164 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.68104734 |
| 165 | base-excision repair, AP site formation (GO:0006285) | 2.67364899 |
| 166 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.66936634 |
| 167 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.66044367 |
| 168 | chromatin assembly or disassembly (GO:0006333) | 2.65260657 |
| 169 | establishment of chromosome localization (GO:0051303) | 2.63642664 |
| 170 | termination of RNA polymerase II transcription (GO:0006369) | 2.61463863 |
| 171 | mitochondrial DNA metabolic process (GO:0032042) | 2.61301970 |
| 172 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.60222877 |
| 173 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.59481998 |
| 174 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.59080162 |
| 175 | histone arginine methylation (GO:0034969) | 2.59027974 |
| 176 | kinetochore organization (GO:0051383) | 2.58418664 |
| 177 | ribosomal large subunit biogenesis (GO:0042273) | 2.57417672 |
| 178 | protein localization to chromosome (GO:0034502) | 2.57245688 |
| 179 | regulation of gene silencing (GO:0060968) | 2.57085967 |
| 180 | pseudouridine synthesis (GO:0001522) | 2.54209725 |
| 181 | negative regulation of chromosome segregation (GO:0051985) | 2.54049013 |
| 182 | telomere organization (GO:0032200) | 2.53966783 |
| 183 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.53261536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.22350678 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.86261444 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.39091028 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.37250066 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.21510038 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.89853593 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.77183017 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.68536482 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.58992350 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.32041929 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.29454272 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24701984 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.23010819 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.19085866 |
| 15 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10495641 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.08341527 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.00091758 |
| 18 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.98612630 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.97972064 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.94458268 |
| 21 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.92626510 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.90102680 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86944990 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86332553 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.85484252 |
| 26 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.79037349 |
| 27 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.76251423 |
| 28 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.76205789 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.71576129 |
| 30 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.67798992 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.67192859 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67185298 |
| 33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.66729681 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.66606271 |
| 35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65994234 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.65770646 |
| 37 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.64749806 |
| 38 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.63924639 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.63032612 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.62404355 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61916235 |
| 42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.59124423 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.57700264 |
| 44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.57602563 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.57470039 |
| 46 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55894147 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53912387 |
| 48 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.49805421 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.49651437 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48789906 |
| 51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47740950 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46095901 |
| 53 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.45659794 |
| 54 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.45659794 |
| 55 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.45659794 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41924917 |
| 57 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.40836847 |
| 58 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.40505835 |
| 59 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.39304181 |
| 60 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.38604208 |
| 61 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38077807 |
| 62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.37262085 |
| 63 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35336241 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33354853 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32626820 |
| 66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31886738 |
| 67 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31638866 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31609017 |
| 69 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.30699721 |
| 70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.28580277 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26871931 |
| 72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.24375308 |
| 73 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23670361 |
| 74 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22343729 |
| 75 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21855316 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21605099 |
| 77 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.21421392 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.20627367 |
| 79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20302301 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18591025 |
| 81 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17248259 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16377424 |
| 83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15115218 |
| 84 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14288141 |
| 85 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13992576 |
| 86 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13618657 |
| 87 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.11340150 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09858567 |
| 89 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.09343727 |
| 90 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09301362 |
| 91 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.09285482 |
| 92 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09085487 |
| 93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08321927 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.07668026 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05406394 |
| 96 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05312355 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03969292 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02740365 |
| 99 | MAF_26560356_Chip-Seq_TH2_Human | 1.01751669 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00984878 |
| 101 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00802188 |
| 102 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00753313 |
| 103 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99729551 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99341251 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98223346 |
| 106 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.97565931 |
| 107 | MYB_26560356_Chip-Seq_TH1_Human | 0.97383669 |
| 108 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96486214 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95973125 |
| 110 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.95698052 |
| 111 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93060221 |
| 112 | MYB_26560356_Chip-Seq_TH2_Human | 0.92971689 |
| 113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92867039 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92386452 |
| 115 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.91090810 |
| 116 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90966987 |
| 117 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90715976 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89873621 |
| 119 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89755480 |
| 120 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89483460 |
| 121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87665909 |
| 122 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.86857457 |
| 123 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.84861520 |
| 124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83838730 |
| 125 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83015871 |
| 126 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.82412488 |
| 127 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.82228368 |
| 128 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.81119180 |
| 129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.79926435 |
| 130 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.79726848 |
| 131 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.76037962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.15621810 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.83301222 |
| 3 | MP0010094_abnormal_chromosome_stability | 3.68285050 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.62898185 |
| 5 | MP0008057_abnormal_DNA_replication | 3.57983410 |
| 6 | MP0003077_abnormal_cell_cycle | 3.36417650 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.75915850 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.63784091 |
| 9 | MP0008058_abnormal_DNA_repair | 2.40724592 |
| 10 | MP0002254_reproductive_system_inflammat | 2.38035239 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.35682607 |
| 12 | MP0001730_embryonic_growth_arrest | 2.24960560 |
| 13 | MP0000350_abnormal_cell_proliferation | 2.19171265 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.18796920 |
| 15 | MP0003186_abnormal_redox_activity | 2.15419597 |
| 16 | MP0010307_abnormal_tumor_latency | 2.11886616 |
| 17 | MP0003941_abnormal_skin_development | 2.08943365 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.06748321 |
| 19 | MP0006035_abnormal_mitochondrial_morpho | 2.02476227 |
| 20 | MP0000490_abnormal_crypts_of | 2.01197239 |
| 21 | MP0001853_heart_inflammation | 1.97897972 |
| 22 | MP0008932_abnormal_embryonic_tissue | 1.90077920 |
| 23 | MP0001727_abnormal_embryo_implantation | 1.86201062 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.78746235 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.76755474 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.76755474 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.74641545 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.73866254 |
| 29 | MP0001672_abnormal_embryogenesis/_devel | 1.72684481 |
| 30 | MP0005380_embryogenesis_phenotype | 1.72684481 |
| 31 | MP0000685_abnormal_immune_system | 1.71598792 |
| 32 | MP0009278_abnormal_bone_marrow | 1.69170725 |
| 33 | MP0001697_abnormal_embryo_size | 1.68690145 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.68300535 |
| 35 | MP0002398_abnormal_bone_marrow | 1.66364475 |
| 36 | MP0002653_abnormal_ependyma_morphology | 1.63192853 |
| 37 | MP0002019_abnormal_tumor_incidence | 1.62890692 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.60240151 |
| 39 | MP0002086_abnormal_extraembryonic_tissu | 1.58347584 |
| 40 | MP0003984_embryonic_growth_retardation | 1.58036199 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.57405105 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.57085598 |
| 43 | MP0002088_abnormal_embryonic_growth/wei | 1.55149906 |
| 44 | MP0002722_abnormal_immune_system | 1.55074329 |
| 45 | MP0004147_increased_porphyrin_level | 1.54664486 |
| 46 | MP0002080_prenatal_lethality | 1.54618750 |
| 47 | MP0002085_abnormal_embryonic_tissue | 1.54597319 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.53910474 |
| 49 | MP0001764_abnormal_homeostasis | 1.53825173 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.53311149 |
| 51 | MP0004197_abnormal_fetal_growth/weight/ | 1.52343382 |
| 52 | MP0003786_premature_aging | 1.52195899 |
| 53 | MP0002084_abnormal_developmental_patter | 1.50872228 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.50389832 |
| 55 | MP0009785_altered_susceptibility_to | 1.47250826 |
| 56 | MP0002796_impaired_skin_barrier | 1.47230322 |
| 57 | MP0000313_abnormal_cell_death | 1.43508826 |
| 58 | MP0002139_abnormal_hepatobiliary_system | 1.40579028 |
| 59 | MP0001800_abnormal_humoral_immune | 1.36734626 |
| 60 | MP0003123_paternal_imprinting | 1.32489637 |
| 61 | MP0002429_abnormal_blood_cell | 1.25031373 |
| 62 | MP0000716_abnormal_immune_system | 1.22753169 |
| 63 | MP0005023_abnormal_wound_healing | 1.22568747 |
| 64 | MP0006292_abnormal_olfactory_placode | 1.20773821 |
| 65 | MP0008260_abnormal_autophagy | 1.20039728 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.19618560 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.19257330 |
| 68 | MP0001835_abnormal_antigen_presentation | 1.18501239 |
| 69 | MP0003195_calcinosis | 1.17571289 |
| 70 | MP0001529_abnormal_vocalization | 1.17456875 |
| 71 | MP0002405_respiratory_system_inflammati | 1.16149112 |
| 72 | MP0002102_abnormal_ear_morphology | 1.15734313 |
| 73 | MP0000858_altered_metastatic_potential | 1.15564705 |
| 74 | MP0003436_decreased_susceptibility_to | 1.13115071 |
| 75 | MP0003566_abnormal_cell_adhesion | 1.11253530 |
| 76 | MP0002420_abnormal_adaptive_immunity | 1.09922765 |
| 77 | MP0005367_renal/urinary_system_phenotyp | 1.09394122 |
| 78 | MP0000516_abnormal_urinary_system | 1.09394122 |
| 79 | MP0003315_abnormal_perineum_morphology | 1.08627398 |
| 80 | MP0001819_abnormal_immune_cell | 1.08604296 |
| 81 | MP0002452_abnormal_antigen_presenting | 1.08036098 |
| 82 | MP0005671_abnormal_response_to | 1.08035035 |
| 83 | MP0001293_anophthalmia | 1.07731028 |
| 84 | MP0009053_abnormal_anal_canal | 1.05901191 |
| 85 | MP0003119_abnormal_digestive_system | 1.05344113 |
| 86 | MP0008995_early_reproductive_senescence | 1.01397456 |
| 87 | MP0002132_abnormal_respiratory_system | 1.01261363 |
| 88 | MP0008877_abnormal_DNA_methylation | 1.01153440 |
| 89 | MP0001849_ear_inflammation | 0.99746643 |
| 90 | MP0002723_abnormal_immune_serum | 0.97617650 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.96672049 |
| 92 | MP0002736_abnormal_nociception_after | 0.96092283 |
| 93 | MP0004133_heterotaxia | 0.94318000 |
| 94 | MP0001915_intracranial_hemorrhage | 0.94070287 |
| 95 | MP0005332_abnormal_amino_acid | 0.92050896 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.91709144 |
| 97 | MP0001919_abnormal_reproductive_system | 0.91677642 |
| 98 | MP0006082_CNS_inflammation | 0.90885157 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89749237 |
| 100 | MP0004019_abnormal_vitamin_homeostasis | 0.89421624 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 0.88687041 |
| 102 | MP0008789_abnormal_olfactory_epithelium | 0.88495416 |
| 103 | MP0001881_abnormal_mammary_gland | 0.88403457 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.87714274 |
| 105 | MP0009697_abnormal_copulation | 0.87581412 |
| 106 | MP0003448_altered_tumor_morphology | 0.87085124 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.85975459 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.85651812 |
| 109 | MP0001188_hyperpigmentation | 0.85270976 |
| 110 | MP0003718_maternal_effect | 0.84276426 |
| 111 | MP0001790_abnormal_immune_system | 0.81693276 |
| 112 | MP0005387_immune_system_phenotype | 0.81693276 |
| 113 | MP0003011_delayed_dark_adaptation | 0.80757943 |
| 114 | MP0005621_abnormal_cell_physiology | 0.79766189 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.78984765 |
| 116 | MP0005025_abnormal_response_to | 0.78831464 |
| 117 | MP0000358_abnormal_cell_content/ | 0.78669407 |
| 118 | MP0002111_abnormal_tail_morphology | 0.78434663 |
| 119 | MP0005000_abnormal_immune_tolerance | 0.78092460 |
| 120 | MP0008469_abnormal_protein_level | 0.76649433 |
| 121 | MP0005384_cellular_phenotype | 0.76332546 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.74435281 |
| 123 | MP0003303_peritoneal_inflammation | 0.73947618 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 0.73690503 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.73670177 |
| 126 | MP0001145_abnormal_male_reproductive | 0.73468809 |
| 127 | MP0001119_abnormal_female_reproductive | 0.73261168 |
| 128 | MP0005451_abnormal_body_composition | 0.71515473 |
| 129 | MP0002210_abnormal_sex_determination | 0.71397296 |
| 130 | MP0001929_abnormal_gametogenesis | 0.70855584 |
| 131 | MP0008770_decreased_survivor_rate | 0.70190325 |
| 132 | MP0002092_abnormal_eye_morphology | 0.69624875 |
| 133 | MP0002419_abnormal_innate_immunity | 0.69262999 |
| 134 | MP0009703_decreased_birth_body | 0.69017112 |
| 135 | MP0002089_abnormal_postnatal_growth/wei | 0.68766324 |
| 136 | MP0005379_endocrine/exocrine_gland_phen | 0.68588709 |
| 137 | MP0000428_abnormal_craniofacial_morphol | 0.67881267 |
| 138 | MP0004947_skin_inflammation | 0.67557271 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.67101756 |
| 140 | MP0001873_stomach_inflammation | 0.66938345 |
| 141 | MP0009840_abnormal_foam_cell | 0.65952499 |
| 142 | MP0005501_abnormal_skin_physiology | 0.65585911 |
| 143 | MP0003121_genomic_imprinting | 0.64197325 |
| 144 | MP0009672_abnormal_birth_weight | 0.63395199 |
| 145 | MP0000371_diluted_coat_color | 0.62162687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.27062027 |
| 2 | Mitochondrial inheritance (HP:0001427) | 4.07554680 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.00851931 |
| 4 | Acute encephalopathy (HP:0006846) | 3.97188814 |
| 5 | Ependymoma (HP:0002888) | 3.88779812 |
| 6 | Increased CSF lactate (HP:0002490) | 3.84818349 |
| 7 | Increased hepatocellular lipid droplets (HP:0006565) | 3.84779304 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.76996872 |
| 9 | Lipid accumulation in hepatocytes (HP:0006561) | 3.68595635 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.65409182 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.65409182 |
| 12 | Selective tooth agenesis (HP:0001592) | 3.61590005 |
| 13 | Renal Fanconi syndrome (HP:0001994) | 3.54504552 |
| 14 | Hepatic necrosis (HP:0002605) | 3.51986198 |
| 15 | Progressive macrocephaly (HP:0004481) | 3.38972173 |
| 16 | Birth length less than 3rd percentile (HP:0003561) | 3.32935499 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 3.30815350 |
| 18 | Cerebral edema (HP:0002181) | 3.21395751 |
| 19 | Basal cell carcinoma (HP:0002671) | 3.18345390 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.14521052 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.09787303 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.00185330 |
| 23 | Lactic acidosis (HP:0003128) | 2.99482297 |
| 24 | Increased serum lactate (HP:0002151) | 2.98108384 |
| 25 | Increased muscle lipid content (HP:0009058) | 2.95122593 |
| 26 | Medulloblastoma (HP:0002885) | 2.90863995 |
| 27 | Degeneration of anterior horn cells (HP:0002398) | 2.90028607 |
| 28 | Abnormality of the anterior horn cell (HP:0006802) | 2.90028607 |
| 29 | Agnosia (HP:0010524) | 2.88808680 |
| 30 | Oral leukoplakia (HP:0002745) | 2.88801691 |
| 31 | Patellar aplasia (HP:0006443) | 2.75097619 |
| 32 | Multiple enchondromatosis (HP:0005701) | 2.73172264 |
| 33 | Abnormality of glycolysis (HP:0004366) | 2.71129618 |
| 34 | Rhabdomyosarcoma (HP:0002859) | 2.71026898 |
| 35 | Reticulocytopenia (HP:0001896) | 2.70513180 |
| 36 | Breast hypoplasia (HP:0003187) | 2.68794189 |
| 37 | Chromsome breakage (HP:0040012) | 2.68274793 |
| 38 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.65885857 |
| 39 | Abnormality of the astrocytes (HP:0100707) | 2.63156249 |
| 40 | Astrocytoma (HP:0009592) | 2.63156249 |
| 41 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.62269025 |
| 42 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.62269025 |
| 43 | Abnormal protein glycosylation (HP:0012346) | 2.62269025 |
| 44 | Abnormal glycosylation (HP:0012345) | 2.62269025 |
| 45 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.61937485 |
| 46 | Rib fusion (HP:0000902) | 2.57529497 |
| 47 | Abnormal number of incisors (HP:0011064) | 2.56907115 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 2.55930911 |
| 49 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.53402412 |
| 50 | Respiratory difficulties (HP:0002880) | 2.51733057 |
| 51 | Exertional dyspnea (HP:0002875) | 2.51021897 |
| 52 | Pancytopenia (HP:0001876) | 2.50118359 |
| 53 | Lethargy (HP:0001254) | 2.48064599 |
| 54 | Absent thumb (HP:0009777) | 2.47973554 |
| 55 | Abnormality of the ileum (HP:0001549) | 2.43044544 |
| 56 | Exercise intolerance (HP:0003546) | 2.42475944 |
| 57 | Rough bone trabeculation (HP:0100670) | 2.42111118 |
| 58 | Respiratory failure (HP:0002878) | 2.40516460 |
| 59 | Aplastic anemia (HP:0001915) | 2.38152768 |
| 60 | Pustule (HP:0200039) | 2.38070637 |
| 61 | Abnormality of lateral ventricle (HP:0030047) | 2.38061911 |
| 62 | Microvesicular hepatic steatosis (HP:0001414) | 2.37066368 |
| 63 | IgM deficiency (HP:0002850) | 2.36536401 |
| 64 | Sparse eyelashes (HP:0000653) | 2.34830206 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.34558436 |
| 66 | Absent radius (HP:0003974) | 2.34371373 |
| 67 | Cleft eyelid (HP:0000625) | 2.34035990 |
| 68 | Myelodysplasia (HP:0002863) | 2.33212931 |
| 69 | Spinal muscular atrophy (HP:0007269) | 2.32804244 |
| 70 | Trismus (HP:0000211) | 2.32514239 |
| 71 | Reduced antithrombin III activity (HP:0001976) | 2.32398177 |
| 72 | Abnormality of chromosome stability (HP:0003220) | 2.31912518 |
| 73 | Meckel diverticulum (HP:0002245) | 2.30828664 |
| 74 | Colon cancer (HP:0003003) | 2.30548602 |
| 75 | Squamous cell carcinoma (HP:0002860) | 2.30463084 |
| 76 | Horseshoe kidney (HP:0000085) | 2.29462852 |
| 77 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.28194226 |
| 78 | Methylmalonic aciduria (HP:0012120) | 2.27436578 |
| 79 | Carpal bone hypoplasia (HP:0001498) | 2.27191804 |
| 80 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.25220028 |
| 81 | Neoplasm of striated muscle (HP:0009728) | 2.24482028 |
| 82 | Abnormality of T cells (HP:0002843) | 2.24268463 |
| 83 | Amaurosis fugax (HP:0100576) | 2.23656098 |
| 84 | Nausea (HP:0002018) | 2.21915761 |
| 85 | Abnormality of the labia minora (HP:0012880) | 2.20903076 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.18479568 |
| 87 | Thrombocytosis (HP:0001894) | 2.18253568 |
| 88 | Abnormal number of erythroid precursors (HP:0012131) | 2.18031472 |
| 89 | Absent forearm bone (HP:0003953) | 2.17544725 |
| 90 | Aplasia involving forearm bones (HP:0009822) | 2.17544725 |
| 91 | Increased nuchal translucency (HP:0010880) | 2.16131425 |
| 92 | Proximal placement of thumb (HP:0009623) | 2.15419701 |
| 93 | Glioma (HP:0009733) | 2.15168939 |
| 94 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.14581378 |
| 95 | Impulsivity (HP:0100710) | 2.14037526 |
| 96 | Prominent nose (HP:0000448) | 2.12287444 |
| 97 | Poikiloderma (HP:0001029) | 2.12000198 |
| 98 | Deviation of the thumb (HP:0009603) | 2.11885441 |
| 99 | Bone marrow hypocellularity (HP:0005528) | 2.11449022 |
| 100 | T lymphocytopenia (HP:0005403) | 2.11252079 |
| 101 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11044436 |
| 102 | Abnormality of the preputium (HP:0100587) | 2.10630051 |
| 103 | Premature graying of hair (HP:0002216) | 2.10477022 |
| 104 | Lymphoma (HP:0002665) | 2.10074184 |
| 105 | Premature ovarian failure (HP:0008209) | 2.09828423 |
| 106 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.09146021 |
| 107 | Macrocytic anemia (HP:0001972) | 2.08975560 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 2.08761046 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.08761046 |
| 110 | Microretrognathia (HP:0000308) | 2.08719884 |
| 111 | Generalized aminoaciduria (HP:0002909) | 2.08395701 |
| 112 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.08119179 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 2.07925626 |
| 114 | Cafe-au-lait spot (HP:0000957) | 2.07462471 |
| 115 | Intestinal fistula (HP:0100819) | 2.06711798 |
| 116 | Neoplasm of the pancreas (HP:0002894) | 2.05874992 |
| 117 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.04696777 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 2.04409002 |
| 119 | CNS demyelination (HP:0007305) | 2.04257206 |
| 120 | Missing ribs (HP:0000921) | 2.04250292 |
| 121 | Tracheoesophageal fistula (HP:0002575) | 2.04168835 |
| 122 | Tongue fasciculations (HP:0001308) | 2.03635086 |
| 123 | Hyperglycinemia (HP:0002154) | 2.03175093 |
| 124 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01236401 |
| 125 | Glycosuria (HP:0003076) | 2.01071520 |
| 126 | Abnormality of urine glucose concentration (HP:0011016) | 2.01071520 |
| 127 | Optic disc pallor (HP:0000543) | 1.99330637 |
| 128 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.98575119 |
| 129 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.98429006 |
| 130 | Abnormality of renal resorption (HP:0011038) | 1.97384454 |
| 131 | Pili torti (HP:0003777) | 1.96876302 |
| 132 | Rectal fistula (HP:0100590) | 1.96813897 |
| 133 | Rectovaginal fistula (HP:0000143) | 1.96813897 |
| 134 | Abnormality of the lower motor neuron (HP:0002366) | 1.96623873 |
| 135 | Cellular immunodeficiency (HP:0005374) | 1.95816220 |
| 136 | Facial hemangioma (HP:0000329) | 1.95646277 |
| 137 | Abnormality of glycine metabolism (HP:0010895) | 1.95261234 |
| 138 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95261234 |
| 139 | Abnormality of T cell number (HP:0011839) | 1.94434559 |
| 140 | Small intestinal stenosis (HP:0012848) | 1.93618466 |
| 141 | Duodenal stenosis (HP:0100867) | 1.93618466 |
| 142 | Hyperphosphaturia (HP:0003109) | 1.92576413 |
| 143 | 11 pairs of ribs (HP:0000878) | 1.92526240 |
| 144 | Leukodystrophy (HP:0002415) | 1.92010155 |
| 145 | 3-Methylglutaconic aciduria (HP:0003535) | 1.91199179 |
| 146 | Hyperglycinuria (HP:0003108) | 1.90548417 |
| 147 | Neoplasm of the oral cavity (HP:0100649) | 1.89687605 |
| 148 | Hepatosplenomegaly (HP:0001433) | 1.89367635 |
| 149 | Cerebral hypomyelination (HP:0006808) | 1.88458609 |
| 150 | Hypoglycemic seizures (HP:0002173) | 1.86695729 |
| 151 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.85150853 |
| 152 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83880580 |
| 153 | Muscle fibrillation (HP:0010546) | 1.83332353 |
| 154 | Hypoglycemic coma (HP:0001325) | 1.82897776 |
| 155 | Recurrent viral infections (HP:0004429) | 1.82864454 |
| 156 | Atresia of the external auditory canal (HP:0000413) | 1.82771914 |
| 157 | Short humerus (HP:0005792) | 1.82353435 |
| 158 | Ragged-red muscle fibers (HP:0003200) | 1.81025107 |
| 159 | Recurrent bronchitis (HP:0002837) | 1.80250149 |
| 160 | IgG deficiency (HP:0004315) | 1.80110024 |
| 161 | Acute lymphatic leukemia (HP:0006721) | 1.78776034 |
| 162 | Hypochromic anemia (HP:0001931) | 1.77480828 |
| 163 | Abnormal neuron morphology (HP:0012757) | 1.77284259 |
| 164 | Abnormality of the motor neurons (HP:0002450) | 1.77284259 |
| 165 | Ulnar bowing (HP:0003031) | 1.76351463 |
| 166 | Stomatitis (HP:0010280) | 1.75848305 |
| 167 | Symptomatic seizures (HP:0011145) | 1.75146372 |
| 168 | Dry hair (HP:0011359) | 1.74543017 |
| 169 | Severe combined immunodeficiency (HP:0004430) | 1.74276855 |
| 170 | Personality changes (HP:0000751) | 1.73760995 |
| 171 | Brittle hair (HP:0002299) | 1.72943087 |
| 172 | Nasal polyposis (HP:0100582) | 1.72510398 |
| 173 | Short 4th metacarpal (HP:0010044) | 1.72376478 |
| 174 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.72376478 |
| 175 | Abnormal trabecular bone morphology (HP:0100671) | 1.71990707 |
| 176 | Increased IgM level (HP:0003496) | 1.70973113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.41499718 |
| 2 | BUB1 | 3.71252261 |
| 3 | MST4 | 3.34843383 |
| 4 | CDK12 | 3.31764617 |
| 5 | MAP3K10 | 3.13042740 |
| 6 | STK16 | 3.02557570 |
| 7 | EEF2K | 2.95038934 |
| 8 | CDC7 | 2.79598763 |
| 9 | NEK2 | 2.56784563 |
| 10 | MAP4K1 | 2.52757171 |
| 11 | WEE1 | 2.47028158 |
| 12 | STK10 | 2.13152457 |
| 13 | TESK2 | 2.12945239 |
| 14 | PBK | 2.11421321 |
| 15 | PKN2 | 2.10341788 |
| 16 | NEK1 | 2.07236403 |
| 17 | PASK | 1.96933686 |
| 18 | ZAK | 1.92793404 |
| 19 | GRK6 | 1.92363050 |
| 20 | EIF2AK1 | 1.87986160 |
| 21 | RPS6KB2 | 1.84923496 |
| 22 | PDK2 | 1.82353798 |
| 23 | CDK7 | 1.76907838 |
| 24 | TRIB3 | 1.76420195 |
| 25 | TTK | 1.75128565 |
| 26 | TRIM28 | 1.69785173 |
| 27 | MAP3K12 | 1.62986864 |
| 28 | FLT3 | 1.62404591 |
| 29 | CDK4 | 1.59761269 |
| 30 | PLK1 | 1.57270253 |
| 31 | NUAK1 | 1.54714177 |
| 32 | PIM2 | 1.51806688 |
| 33 | PAK4 | 1.50680976 |
| 34 | PIM1 | 1.46663444 |
| 35 | CDK19 | 1.41879006 |
| 36 | ERN1 | 1.41676312 |
| 37 | EPHA2 | 1.40719248 |
| 38 | DYRK3 | 1.39455352 |
| 39 | ATR | 1.39118938 |
| 40 | LIMK1 | 1.33625410 |
| 41 | TSSK6 | 1.33236340 |
| 42 | AURKB | 1.26524450 |
| 43 | MAP3K8 | 1.23140586 |
| 44 | NME1 | 1.19442996 |
| 45 | NME2 | 1.18109366 |
| 46 | ALK | 1.17923494 |
| 47 | ICK | 1.12607316 |
| 48 | CHEK1 | 1.12501879 |
| 49 | TAF1 | 1.11330052 |
| 50 | LRRK2 | 1.08424581 |
| 51 | SRPK1 | 1.05991969 |
| 52 | ZAP70 | 1.04084381 |
| 53 | TLK1 | 1.03897677 |
| 54 | CHEK2 | 1.03034316 |
| 55 | ACVR1B | 1.01989277 |
| 56 | CSF1R | 1.00047281 |
| 57 | MUSK | 0.98983603 |
| 58 | SCYL2 | 0.95612537 |
| 59 | BRSK2 | 0.94603473 |
| 60 | MAP3K11 | 0.92573573 |
| 61 | STK4 | 0.92502639 |
| 62 | DYRK2 | 0.88630626 |
| 63 | RPS6KA4 | 0.88490078 |
| 64 | CSNK1G3 | 0.87430597 |
| 65 | MAPKAPK3 | 0.85545506 |
| 66 | MKNK2 | 0.85018161 |
| 67 | CDK2 | 0.83239787 |
| 68 | TYK2 | 0.81781180 |
| 69 | CDK6 | 0.80366216 |
| 70 | EIF2AK3 | 0.80057642 |
| 71 | BRSK1 | 0.77476677 |
| 72 | AURKA | 0.76820985 |
| 73 | IKBKE | 0.75652730 |
| 74 | JAK3 | 0.75448293 |
| 75 | BTK | 0.75153379 |
| 76 | MTOR | 0.74846593 |
| 77 | BMX | 0.73844782 |
| 78 | MAP4K2 | 0.73406799 |
| 79 | TYRO3 | 0.73320079 |
| 80 | CSNK1G1 | 0.70122621 |
| 81 | EIF2AK2 | 0.69279775 |
| 82 | PLK4 | 0.68525745 |
| 83 | MATK | 0.67683430 |
| 84 | ATM | 0.67675910 |
| 85 | TXK | 0.67541280 |
| 86 | GRK1 | 0.66225022 |
| 87 | SIK3 | 0.64781069 |
| 88 | CSK | 0.64243320 |
| 89 | TESK1 | 0.63675781 |
| 90 | MAPK11 | 0.63557510 |
| 91 | ILK | 0.63534579 |
| 92 | TGFBR1 | 0.63340616 |
| 93 | SMG1 | 0.63257147 |
| 94 | TBK1 | 0.62990192 |
| 95 | BLK | 0.55921942 |
| 96 | BRD4 | 0.55732874 |
| 97 | MAP2K3 | 0.55408674 |
| 98 | FGFR3 | 0.54796496 |
| 99 | PRKCI | 0.54485574 |
| 100 | MAP2K7 | 0.53279743 |
| 101 | ABL2 | 0.53101421 |
| 102 | RPS6KL1 | 0.53055066 |
| 103 | RPS6KC1 | 0.53055066 |
| 104 | FGR | 0.52891733 |
| 105 | DAPK1 | 0.52130659 |
| 106 | FGFR4 | 0.52050903 |
| 107 | PDGFRA | 0.50745514 |
| 108 | AKT2 | 0.50329097 |
| 109 | CSNK1G2 | 0.50227678 |
| 110 | ITK | 0.49778022 |
| 111 | VRK1 | 0.49480784 |
| 112 | MELK | 0.49461795 |
| 113 | TEC | 0.49228042 |
| 114 | CHUK | 0.49220911 |
| 115 | CDK8 | 0.49087095 |
| 116 | DYRK1B | 0.48626952 |
| 117 | DAPK3 | 0.48426559 |
| 118 | RPS6KA6 | 0.48373807 |
| 119 | CSNK2A2 | 0.48260959 |
| 120 | PAK1 | 0.48046601 |
| 121 | CLK1 | 0.47256893 |
| 122 | KDR | 0.46783572 |
| 123 | KIT | 0.46640170 |
| 124 | IKBKB | 0.46030995 |
| 125 | PLK3 | 0.45745144 |
| 126 | CDK1 | 0.45517484 |
| 127 | BCKDK | 0.44976082 |
| 128 | CSNK1A1L | 0.44794233 |
| 129 | MKNK1 | 0.42722582 |
| 130 | FES | 0.42316602 |
| 131 | FGFR1 | 0.42203466 |
| 132 | LYN | 0.42008042 |
| 133 | STK3 | 0.41582424 |
| 134 | LCK | 0.41383846 |
| 135 | RPS6KA5 | 0.39927045 |
| 136 | CSNK2A1 | 0.39509468 |
| 137 | CCNB1 | 0.36932241 |
| 138 | WNK3 | 0.35956505 |
| 139 | ARAF | 0.35592450 |
| 140 | BMPR1B | 0.31624417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.35744539 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.84537666 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.42203595 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.14101134 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 3.05836259 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01149372 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.84136314 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.58422332 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.58228070 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.55622595 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.45801161 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.28896816 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.28574508 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.11417346 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.09520277 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 2.08810875 |
| 17 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.91212780 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.86132646 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.84027856 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.78809848 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.75277105 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.75001827 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.73342402 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.71505843 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63656625 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.61771427 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.59686102 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44931877 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43550922 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41454222 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.38926875 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.35757952 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32320234 |
| 34 | Basal transcription factors_Homo sapiens_hsa03022 | 1.27329559 |
| 35 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23163124 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.22947977 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22034711 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21821566 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21806968 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18130021 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16963263 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.16169437 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16128316 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.12353571 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.09171684 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08864021 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04309746 |
| 48 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04021819 |
| 49 | Allograft rejection_Homo sapiens_hsa05330 | 0.96840123 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95234150 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92566930 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91909731 |
| 53 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.91564433 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.90918474 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90857895 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89948586 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88488341 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.87907172 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87871766 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87250815 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.87125848 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.86816741 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86742490 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84590746 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84180322 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84132424 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83961407 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82877802 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.82424702 |
| 70 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82028177 |
| 71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.81467673 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81388036 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79703372 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79222588 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77396301 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77098329 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76498955 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75431043 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75103245 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74924251 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.74665874 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.74325216 |
| 83 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74179206 |
| 84 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73781153 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.73485324 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73350367 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72249023 |
| 88 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71347033 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.70405665 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69865941 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.69640072 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69536632 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69523726 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68916226 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.68863594 |
| 96 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.68687572 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67101898 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60988898 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60539558 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60103967 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59456986 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58469805 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57262706 |
| 104 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56468821 |
| 105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56379597 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56124988 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55804263 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.55610534 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54763348 |
| 110 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.54384610 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51884525 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51445760 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49336818 |
| 114 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49310333 |
| 115 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49143513 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48438798 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48372934 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47433120 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47204663 |
| 120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46642551 |
| 121 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46598755 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.45964153 |
| 123 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45730265 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44752153 |
| 125 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44457101 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.43583329 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43213533 |
| 128 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42496695 |
| 129 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38870449 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37787212 |
| 131 | Adherens junction_Homo sapiens_hsa04520 | 0.37476510 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37383540 |
| 133 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36135755 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35493552 |
| 135 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.34733590 |
| 136 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34256905 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33512624 |
| 138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33222222 |
| 139 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32737629 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32481530 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31322302 |
| 142 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29871249 |
| 143 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27413257 |
| 144 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27270703 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26247779 |
| 146 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.23887879 |
| 147 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.23294790 |
| 148 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23082196 |

